Antimicrobial activities of mefloquine and a series of related compounds

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 848-852

  Kunin, C M ^a   Ellis, W Y ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B DERIVATIVE; GENTAMICIN; MEFLOQUINE; METICILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA; CELL MEMBRANE; CRYPTOCOCCUS NEOFORMANS; DRUG ACTIVITY; ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIMALARIALS; BACTERIA; DNA TOPOISOMERASES, TYPE II; DRUG SYNERGISM; FUNGI; GENTAMICINS; MEFLOQUINE; MICROBIAL SENSITIVITY TESTS; NUCLEIC ACIDS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 0034026489     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.848-852.2000     Document Type: Article

References (15)

1. Bermudez, L. E., P. Kolonoski, M. Wu, P. A. Aralar, C. B. Inderlied, and L. S. Young. 1999. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex. Antimicrob. Agents Chemother. 43:1870-1875.
2. Bromke, B. J., and M. McGinn. 1993. In vitro susceptibility of selected non-protozoa to mefloquine. Acta Microbiol. Hung. 40:387-389.
3. Brown, R. E., F. A. Stancato, and A. D. Wolfe. 1979. The effects of mefloquine on Escherichia coli. Life Sci. 25:1857-1864.
4. Cleeland, R., and E. Grunberg. 1986. Laboratory evaluation of new antibiotics in vitro and in experimental animal infections, p. 833-834. In V. Lorian (ed.). Antibiotics in laboratory medicine, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
5. 4a. Ellis, W. Y., and C. M. Kunin. October 1999. U.S. patent 5,965,572.
6. Gilman, A. G., et al. (ed.). 1993. Goodman and Gilman's the pharmacologic basis of therapeutics, 8th ed. McGraw-Hill Book Co., New York, N.Y.
7. Inoue, Y., S. Kenichi, T. Fujii, K. Hirai, M. Inoue, S. Iyobe, and S. Mitsuhashi. 1987. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant. J. Bacteriol. 169: 2322-2325.
8. Mehaffy, P. C., M. S. Barrett, S. D. Putnam, and R. N. Jones. 1995. Antigonococcal activity of 11 drugs used for therapy or prophylaxis of malaria. Diagn. Microbiol. Infect. Dis. 23:11-13.
9. +-ATPase of Streptococcus pneumoniae. J. Bacteriol. 178:2455-2458.
10. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
11. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 157:1064-1073.
13. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
14. Todd, G. D., A. P. Hopperus Buma, M. D. Green, C. A. Jaspers, and H. O. Lobel. 1997. Comparison of whole blood and serum levels of mefloquine and its carboxylic acid derivative. Am. J. Trop. Med. Hyg. 57:399-402.
15. Weidekamm, E., G. Rusing, H. Caplain, F. Sorgel, and C. Crevoisier. 1998. Lack of bioequivalence of a generic mefloquine tablet with the standard product. Eur. J. Clin. Pharmacol. 54:615-619.